Cheyne Capital Management (UK)’s Aclaris Therapeutics ACRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-50,964
Closed -$803K 23
2022
Q4
$803K Buy
+50,964
New +$803K 1.4% 26